BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND CCNE1, CCNE, 898, ENSG00000105173, P24864 AND Treatment
34 results:

  • 1. Novel Complex of Zinc (II) Dichloroethylenediamine: Synthesis, Characterization, In-silico, and In-vitro Evaluation against Cervical cancer Cells.
    Raya I; Kartina D; Wijaya RI; Irfandi R; Abdalrazaq EA; Prihantono P; Santi S; Pratiwi E; Khaerunnisa AB; Luthfiana D; Musa B; Natsir H; Maming M; Zainuddin ZD; Ramlawati R; Fudholi A; Usman AN; Supratman U; Mazaya M; Sufiandi S
    Asian Pac J Cancer Prev; 2023 Dec; 24(12):4155-4165. PubMed ID: 38156851
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Endometrial polyps effect on pregnancy outcomes in infertile women with minimal/mild endometriosis: A retrospective study.
    Hu Y; Xiang Y; Huang W
    J Obstet Gynaecol Res; 2023 Dec; 49(12):2946-2951. PubMed ID: 37723936
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Immunohistochemical and molecular analysis of an α-fetoprotein-producing cervical adenocarcinoma with clear cell morphology.
    Kuriyama S; Yano M; Kusaba T; Zaitsu S; Nishida H; Yasuda M; Nasu K
    Med Mol Morphol; 2023 Mar; 56(1):20-27. PubMed ID: 36183278
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clavien-Dindo classification and risk prediction model of complications after robot-assisted radical hysterectomy for cervical cancer.
    Ling H; Wang G; Yi B; Li Z; Zhu S
    J Robot Surg; 2023 Apr; 17(2):527-536. PubMed ID: 35913623
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. ccne1 amplification is synthetic lethal with PKMYT1 kinase inhibition.
    Gallo D; Young JTF; Fourtounis J; Martino G; Álvarez-Quilón A; Bernier C; Duffy NM; Papp R; Roulston A; Stocco R; Szychowski J; Veloso A; Alam H; Baruah PS; Fortin AB; Bowlan J; Chaudhary N; Desjardins J; Dietrich E; Fournier S; Fugère-Desjardins C; Goullet de Rugy T; Leclaire ME; Liu B; Bhaskaran V; Mamane Y; Melo H; Nicolas O; Singhania A; Szilard RK; Tkáč J; Yin SY; Morris SJ; Zinda M; Marshall CG; Durocher D
    Nature; 2022 Apr; 604(7907):749-756. PubMed ID: 35444283
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical results of image-guided interstitial brachytherapy with or without external beam radiotherapy for postsurgical vaginal recurrence of cervical and endometrial cancers.
    Kanemoto A; Sugita T; Ayukawa F; Takahashi K; Horiuchi A; Haino K; Kikuchi A
    Jpn J Radiol; 2022 Jun; 40(6):639-644. PubMed ID: 34851502
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pattern of relapse in patients with stage IB1 cervical cancer after radical hysterectomy as primary treatment. Minimally invasive surgery vs. open approach. Systematic review and meta-analysis.
    Manzour N; Núñez-Cordoba JM; Chiva L; Chacón E; Boria F; Vara-García J; Rodriguez-Velandia YP; Minguez JA; Alcazar JL
    Gynecol Oncol; 2022 Feb; 164(2):455-460. PubMed ID: 34848071
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. WEE1i-ATRi combination therapy: a promising low-dose treatment for
    Goehring L; Huang TT
    Cell Rep Med; 2021 Sep; 2(9):100402. PubMed ID: 34622238
    [No Abstract]    [Full Text] [Related]  

  • 9. uterine serous carcinoma: key advances and novel treatment approaches.
    Ferriss JS; Erickson BK; Shih IM; Fader AN
    Int J Gynecol Cancer; 2021 Aug; 31(8):1165-1174. PubMed ID: 34210768
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Characteristics of progestin-insensitive early stage endometrial cancer and atypical hyperplasia patients receiving second-line fertility-sparing treatment.
    Zhou S; Xu Z; Yang B; Guan J; Shan W; Shi Y; Chen X
    J Gynecol Oncol; 2021 Jul; 32(4):e57. PubMed ID: 34085795
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. uterine serous carcinoma.
    Bogani G; Ray-Coquard I; Concin N; Ngoi NYL; Morice P; Enomoto T; Takehara K; Denys H; Nout RA; Lorusso D; Vaughan MM; Bini M; Takano M; Provencher D; Indini A; Sagae S; Wimberger P; Póka R; Segev Y; Kim SI; Candido Dos Reis FJ; Lopez S; Mariani A; Leitao MM; Raspagliesi F; Panici PB; Di Donato V; Muzii L; Colombo N; Scambia G; Pignata S; Monk BJ
    Gynecol Oncol; 2021 Jul; 162(1):226-234. PubMed ID: 33934848
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinicopathologic and Genomic Analysis of
    Momeni-Boroujeni A; Dahoud W; Vanderbilt CM; Chiang S; Murali R; Rios-Doria EV; Alektiar KM; Aghajanian C; Abu-Rustum NR; Ladanyi M; Ellenson LH; Weigelt B; Soslow RA
    Clin Cancer Res; 2021 May; 27(9):2613-2623. PubMed ID: 33602681
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Integrated bioinformatic analysis of miR-15a/16-1 cluster network in cervical cancer.
    S S; Shukla V; Khan GN; Eswaran S; Adiga D; Kabekkodu SP
    Reprod Biol; 2021 Mar; 21(1):100482. PubMed ID: 33548740
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Optimal method for metabolic tumour volume assessment of cervical cancers with inter-observer agreement on [18F]-fluoro-deoxy-glucose positron emission tomography with computed tomography.
    Arshad MA; Gitau S; Tam H; Park WE; Patel NH; Rockall A; Aboagye EO; Bharwani N; Barwick TD
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):2009-2023. PubMed ID: 33313962
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Neoadjuvant Chemotherapy Followed by Radical Surgery versus Concurrent Chemo-Radiotherapy in the treatment of Locally Advanced Cervical cancer: A Multicenter Retrospective Analysis.
    Sala P; Bogliolo S; Barra F; Fazio A; Maramai M; Cassani C; Gardella B; Babilonti L; Giannelli F; Mammoliti S; Spinillo A; Ferrero S; Valenzano Menada M; Costantini S; Bruzzi P; Marchiolè P
    J Invest Surg; 2022 Feb; 35(2):308-314. PubMed ID: 33289585
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Bioinformatic screening for candidate biomarkers and their prognostic values in endometrial cancer.
    Li Y; Li L
    BMC Genet; 2020 Sep; 21(1):113. PubMed ID: 32962636
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Cost of care for the initial management of cervical cancer in women with commercial insurance.
    Blanco M; Chen L; Melamed A; Tergas AI; Khoury-Collado F; Hou JY; St Clair CM; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Am J Obstet Gynecol; 2021 Mar; 224(3):286.e1-286.e11. PubMed ID: 32818476
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. E6 hijacks KDM5C/lnc_000231/miR-497-5p/ccne1 axis to promote cervical cancer progression.
    Zhang Y; Li X; Zhang J; Mao L
    J Cell Mol Med; 2020 Oct; 24(19):11422-11433. PubMed ID: 32818316
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The Capulana study: a prospective evaluation of cervical cancer screening using human papillomavirus testing in Mozambique.
    Salcedo MP; Oliveira C; Andrade V; Mariano AAN; Changule D; Rangeiro R; Monteiro ECS; Baker E; Phoolcharoen N; Varon ML; Thomas JP; Castle PE; Fregnani JHTG; Schmeler KM; Lorenzoni C
    Int J Gynecol Cancer; 2020 Sep; 30(9):1292-1297. PubMed ID: 32737122
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. MRI texture features differentiate clinicopathological characteristics of cervical carcinoma.
    Wang M; Perucho JAU; Tse KY; Chu MMY; Ip P; Lee EYP
    Eur Radiol; 2020 Oct; 30(10):5384-5391. PubMed ID: 32382845
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.